Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study

This multicenter, prospective trial was conducted to develop an effective and safe reinduction regimen for marrow-relapsed pediatric acute lymphoblastic leukemia (ALL) by modifying the dose of idarubicin. Between 2006 and 2009, the trial accrued 44 patients, 1 to 21 years old with first marrow-relap...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Korean Med Sci
Huvudupphovsmän: Koh, Kyung-Nam, Im, Ho Joon, Kim, Hyery, Kang, Hyoung Jin, Park, Kyung Duk, Shin, Hee Young, Ahn, Hyo Seop, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Lim, Young Tak, Park, Jun Eun, Park, Byung-Kiu, Park, Hyeon Jin, Seo, Jong Jin
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Korean Academy of Medical Sciences 2017
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334163/
https://ncbi.nlm.nih.gov/pubmed/28244291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2017.32.4.642
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk